Anterior lenticonus is an ocular abnormality that can occur in Alport’s syndrome. In this study, Scheimpflug slit imaging analyses were employed for quantitative and objective evaluation of lens changes associated with Alport’s syndrome. It was determined that while the apices of the lenticular protrusions are central in the vertical plane, they are nasally displaced in the horizontal meridian. The eccentricity and dimensions of the diameters and thicknesses of the conical aberration are highly correlated in both eyes. Lens thickness and anterior chamber depth do not differ between eyes. Densitometrically similar differences are apparent in the cortex and nuclear regions although evidence of overt opacification may or may not be present. The data strongly suggest that the physical parameters of the lenticonus are consistent with the constraints imposed by the pupil. Changes observed in the cornea and the vitreous may be associated with the syndrome.

Keywords:
Alport’s syndrome, Lens, Lenticonus, Scheimpflug imaging, Quantitative assessment, Biometry, Densitometry, Cataract, Cornea, Vitreous
1.
Colville DJ, Savige J: Alport syndrome. A review of the ocular manifestations. Ophthalmic Genet 1997;18:161–173.
2.
Worgul BV: The lens; in Jakobiec F (ed): Ocular Anatomy, Embryology and Teratology. Philadelphia, Harper & Row, 1982, chapter 12.
3.
Knapp H: Ein Fall von Lenticonus posterior. Arch Augenheilkd 1891;22:28–31.
4.
Jaworski A: Ein Fall von Lenticonus anterior und über dessen Entstehen. Graefes Arch Clin Exp Ophthalmol 1910;65:313–317.
5.
Alport AC: Hereditary familial congenital hemorrhagic nephritis. BMJ 1927;i:504–506.
6.
Arnott EJ, Crawfurd MD, Toghill PJ: Anterior lenticonus and Alport’s syndrome. Br J Ophthalmol 1966;50:390–402.
7.
Nielsen CE: Lenticonus anterior and Alport’s syndrome. Acta Ophthalmol (Copenh) 1978;56:518–527.
8.
Worgul BV, Kundiev Y, Likhtarev I, Sergienko N, Wegener A, Medvedovsky CP: Use of subjective and nonsubjective methodologies to evaluate lens radiation damage in exposed populations – an overview. Radiat Environ Biophys 1996;35:137–144.
9.
Egner P: Entwicklung eines elektronischen Scheimpflugsystems zur Untersuchung von Linsentrübungen. Aachen, Shaker, 1998.
10.
Sasaki K, Sakamoto Y, Shibata T, Emori Y: The multipurpose camera: A new anterior eye segment analysis system. Ophthalmic Res 1990;22(suppl 1):3–8.
11.
Junk AK, Stefani FH, Ludwig K: Bilateral anterior lenticonus Scheimpflug documentation and ultrastructural confirmation of Alport syndrome in the lens capsule. Arch Ophthalmol 2000;118:895–897.
12.
Eriksson AW, Fellman J, Nieminen H, Forsius H: Influence of age on the position and size of the iris frill and the pupil. Acta Ophthalmol (Copenh) 1965;43:629–641.
13.
Streeten BW, Robinson MR, Wallace R, Jones DB: Lens capsule abnormalities in Alport’s syndrome. Arch Ophthalmol 1987;105:1693–1697.
14.
Perrin D: Le syndrome d’Alport (néphropathies héréditaires avec surdité et atteinte oculaire). Ann Ocul 1964;197:329–346.
15.
Hosada Y, Okada M, Matsumura M, Ogino N, Honda Y, Nagai Y: Intravitreal neovascular tissue of proliferative diabetic retinopathy: An immunohistochemical study. Ophthalmic Res 1992;24:260–264.
© 2003 S. Karger AG, Basel
2003
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.